Intelligent BIO Solutions Inc. income statement

In fiscal 2026, Intelligent BIO Solutions Inc. reported revenue of $4.2m, up 38.1% on the year before, operating income of −$12.6m (a -299.1% margin) and net income of −$12.4m, or −$8.44 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Intelligent BIO Solutions Inc.: income statement, annual
Fiscal year	2020Jun 2020	2021Jun 2021	2022Jun 2022	2023Jun 2023	2024Jun 2024	2025Jun 2025	2026Jun 2026
Revenue	0	2	0	1	3	3	4
Cost of revenue	—	—	—	1	2	2	2
Gross profit	—	—	—	0	1	1	2
Selling, general and administrative	—	—	—	—	—	9	11
General and administrative	2	3	5	8	9	—	—
Operating income	−3	−6	−8	−13	−10	−11	−13
Interest expense	—	—	—	—	0	0	0
Income before tax	−3	−7	—	—	—	—	—
Net income	−3	−7	−8	−11	−10	−11	−12
Diluted EPS	−$0.06	−$24.48	−$20.39	−$19.05	−$19.14	−$20.04	−$8.44
Diluted shares (average)	—	—	—	—	—	—	1m
EBITDA	—	—	−8	−12	−9	−10	−11

US$ thousands unless shown otherwise. Fiscal quarters.

Intelligent BIO Solutions Inc.: income statement, quarterly
Quarter	2025 Q1Sept 2024	2025 Q2Dec 2024	2025 Q3Mar 2025	2025 Q4Jun 2025	2026 Q1Sept 2025	2026 Q2Dec 2025	2026 Q3Mar 2026	2026 Q4Jun 2026
Revenue	998	741	902	411	1,112	897	1,061	1,146
Cost of revenue	525	384	387	508	594	437	525	609
Gross profit	347	223	341	336	518	460	535	537
Selling, general and administrative	—	1,809	2,415	2,723	—	2,337	2,459	2,990
General and administrative	1,949	—	—	—	2,660	—	—	—
Operating income	−2,725	−2,264	−2,560	−3,106	−3,000	−2,636	−2,947	−3,969
Interest expense	22	14	8	5	4	56	4	3
Net income	−2,686	−2,249	−2,544	−3,090	−2,983	−2,678	−2,863	−3,908
Diluted EPS	−$7.00	−$4.96	−$4.41	−$4.12	−$3.50	−$2.82	−$1.80	−$0.90
EBITDA	−2,484	−1,959	−2,258	−2,862	−2,742	−2,354	−2,657	−3,681

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: CNSY vs INBS BMRA vs INBS INBS vs MCTA ICCM vs INBS

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Intelligent BIO Solutions Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Intelligent BIO Solutions Inc.